Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces

Leukemia Research
Michelle J HolderJohn Gordon

Abstract

Here we report that B cell receptor (BCR) engagement rapidly improves the capacity of CD20 to be accessed by cognate antibody at model Burkitt's lymphoma cell surfaces. None of eight other surface molecules demonstrated such BCR-dependent enhancement of ligand binding while the quantity of accessible CD20 remained unchanged on either CD19 or CD40 engagement. Neither the actin-depolymerizing agent cytochalasin D nor inhibitors targeting signalling pathways associated with the BCR attenuated the CD20 increase that could be uncoupled from BCR endocytosis. Instead, a role for lipid rafts was indicated both from the inhibitory actions of cholesterol-sequestering methyl-beta-cyclodextrin and direct analysis of CD20 redistribution using sucrose density gradients and confocal microscopy. Whether such observations could find application in CD20-directed therapies where success can be compromised by otherwise low-level expression of target antigen is discussed.

References

Oct 28, 1994·Biochemical and Biophysical Research Communications·V Sanchez-MargáletC K Sung
Sep 9, 1997·Biochemistry·G GimplF Fahrenholz
Oct 3, 1999·Biochemistry·L PangS Wang
Nov 24, 1999·The Journal of Laboratory and Clinical Medicine·A K Gopal, O W Press
Mar 27, 2002·International Reviews of Immunology·J C PoeT F Tedder
Oct 18, 2002·Immunology·Julie P DeansMaria J Polyak
Oct 24, 2002·Blood·Bruce D Cheson
Nov 22, 2002·Leukemia Research·Arthur E Frankel
Aug 16, 2003·The Journal of Biological Chemistry·Haidong LiJulie P Deans

❮ Previous
Next ❯

Citations

Nov 4, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick J EngelbertsFrank J Beurskens
Oct 17, 2006·Oncogene·J H Reiling, D M Sabatini
Dec 24, 2005·Molecular Cancer Therapeutics·Bruce F IsraelShannon C Kenney

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.